menu search

Scancell makes strong progress with lead immunotherapy assets

Key highlights for biotech group Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF)'s financial year ending April 30 included a positive data reading arising...

October 31, 2023, 4:48 am

Mallinckrodt to present data on terlivaz® (terlipressin) for injection in adult patients with hepatorenal syndrome (hrs) at the american college of gastroenterology (acg) annual scientific meeting

– Findings from two clinical studies and one health economic database analysis provide insight into HRS treatment outcomes with TERLIVAZ,1 patients'...

October 22, 2023, 3:05 pm

Shareholder alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of alnylam pharmaceuticals, inc.(alny)

NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of Alnylam Pharmaceuticals, In...

October 19, 2023, 5:13 pm

Shareholder alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of alnylam pharmaceuticals, inc.

NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of Alnylam Pharmaceuticals, In...

October 17, 2023, 10:06 pm

What makes renalytix ai plc sponsored adr (rnlx) a new strong buy stock

renalytix AI PLC Sponsored ADR (RNLX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting gro...

October 16, 2023, 1:32 pm

Zyversa therapeutics announces peer-reviewed publication in nature reviews nephrology substantiating var 200’s rationale for mediating transport of cholesterol and lipids out of kidney cells to attenu

This review paper summarizes numerous research studies that address the role of kidney cholesterol and lipid accumulation in the development and progr...

October 11, 2023, 11:05 am

Zyversa therapeutics announces peer-reviewed publication in nature reviews nephrology substantiating var 200’s rationale for mediating transport of cholesterol and lipids out of kidney cells to attenu

This review paper summarizes numerous research studies that address the role of kidney cholesterol and lipid accumulation in the development and progr...

October 11, 2023, 11:05 am

Neurocrine's crinecerfont delivered, but the street has been slow to reward the success

Neurocrine Biosciences has reported very positive Phase III results for crinecerfont in adult and pediatric congenital ad...

October 11, 2023, 3:44 am

Novo nordisk to stop ozempic trial to treat renal impairment early

Denmark-based drugmaker Novo Nordisk said on Tuesday it will stop a trial studying Ozempic, its popular diabetes and weight-loss drug, to treat ...

October 10, 2023, 5:30 pm

renalytix sinks to near year low despite news of strengthening us patents

renalytix PLC (AIM:RENX) shares fell 12% to 46.09p after it said newly allowed US patents further st...

October 6, 2023, 4:26 am

renalytix ai plc sponsored adr (rnlx) loses -44.61% in 4 weeks, here's why a trend reversal may be around the corner

renalytix AI PLC Sponsored ADR (RNLX) is technically in oversold territory now, so the heavy selling pr...

October 5, 2023, 11:17 am

renalytix surges 28% medicaid news

Shares of renalytix PLC (AIM:RENX) surged 28% in early trading after the Centers for Medicare & Medicai...

October 3, 2023, 4:09 am

renalytix plc (rnlx) q4 2023 earnings call transcript

renalytix Plc (NASDAQ:RNLX ) Q4 2023 Earnings Conference Call September 28, 2023 8:30 AM ET Company Par...

September 29, 2023, 8:43 pm

Fda accepts merck (mrk) snda for welireg in renal cell carcinoma

The FDA filing is supported by data from a late-stage study that shows that Merck's (MRK) Welireg achieved statistically significant and clinically me...

September 20, 2023, 12:02 pm

Neurocrine needs a meaningful clinical win to break out, and crinecerfont could do it

Neurocrine Biosciences needs a clinical win after years of disappointing results and stagnant stock performance. The upcoming Phase III data on crinec...

August 25, 2023, 6:01 pm

Why medtronic stock dropped today

Medtronic shares are down today after the company announced mixed voting results from the U.S. FDA's Circulatory System Devices Panel on its Symplicit...

August 24, 2023, 4:39 pm

Medtronic shares fall after fda advisors' lukewarm vote on blood-pressure treatment device

Medtronic PLC shares MDT, -0.05% were down 1.3% premarket on Thursday after advisors to the U.S. Food and Drug Administration had a mixed reaction to ...

August 24, 2023, 8:09 am

Merck's (mrk) welireg meets renal cell carcinoma study goals

Based on interim data from a late-stage study, Merck's (MRK) Welireg achieves statistically significant improvements in one of the study's dual endpoi...

August 21, 2023, 3:02 pm

Fda grants fast track designation to ivs-3001, a car-t cell therapy in the treatment of renal cell carcinoma

Houston, TX, USA, July 31, 2023 (GLOBE NEWSWIRE) — Invectys, Inc., a clinical-stage immuno-oncology company focused on developing novel therapies fo...

July 31, 2023, 10:00 am

renalytix jumps on middle east distribution deal, 'region with most diabetes globally'

renalytix PLC (AIM:RENX) shares ramped 7.5% higher to 128.95p on Friday morning after it announced a ...

July 21, 2023, 4:10 am


Search within

Pages Search Results: